SCHEMBL16624866

SCHEMBL16624866

CC(C)c1cccc2cc[n+]([O-])cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNN2 Q9H2S1 5/20 0.39
KCNN3 Q9UGI6 5/20 0.39
CYP1A2 P05177 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
FAAH O00519 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
LMNA P02545 1/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
GABRB1 P18505 1/20 0.36
PTGS1 P23219 1/20 0.36
SLC6A2 P23975 1/20 0.36
HTR2C P28335 1/20 0.36
GABRA5 P31644 1/20 0.36
GABRA3 P34903 1/20 0.36
HTR2B P41595 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2609992 0.86 GABRA1 (0.36) KCNN2KCNN3CYP1A2GABRA1GABRG2
SCHEMBL15631176 0.80 KCNN2 (0.40) KCNN2KCNN3CYP1A2GABRA1GABRG2
SCHEMBL3696572 0.76 CYP2A6 (0.50) CYP1A2CYP3A4HPGDTSHRGPR84
SCHEMBL1491297 0.75 ACHE (0.58) ACHEBCHE
Hydrochloric Acid SCHEMBL1759280 0.74 ACHE (0.56) ACHEBCHE
SCHEMBL66681 0.72 ALDH1A1 (0.60) CYP1A2GABRA1GABRG2GABRB3FAAH
SCHEMBL31280106 0.72 ACHE (0.39) CA1CA2BLMGPR84ACHE
SCHEMBL30727434 0.72 CYP2A6 (0.50) CYP1A2GPR84ACHEBCHEALDH1A1
SCHEMBL6793116 0.72 ACHE (0.41) LMNAGPR84ACHEBCHE
SCHEMBL3579335 0.72 ACHE (0.39) CA1CA2BLMGPR84ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150099781-A1 Compounds and Methods for Treating Mammalian Gastrointestinal Microbial Infections NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2015-04-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150099781-A1 Compounds and Methods for Treating Mammalian Gastrointestinal Microbial Infections IMPDH1, IMPDH2, IMPA1 KCNN2 4809/4885KCNN3 4728/4885CYP1A2 183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.